의약용 당단백질에 부가된 당사슬의 중요성

참고문헌 (40)

1. Aebi M, "N-glycan structures: recognition and processing in the ER", Trends Biochem Sci, 35, pp.74~82 (2010)
2. Anthony RM, "Recapitulation of IVIG antiinflammatory activity with a recombinant IgG Fc", Science, 320, pp.373~376 (2008)
3. Ashwell G, "A protein from mammalian liver that specifically binds galactose-terminated glycoproteins", Methods Enzymol, 50, pp.287~288 (1978)
4. Boyd PN, "The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H", Mol Immunol, 32, pp.1311~1318 (1995)
5. Chavan M, "Subunits of the translocon interact with components of the oligosaccharyltransferase complex", J Biol Chem, 280, pp.22917~22924 (2005)
6. Chou HH, "Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution", Proc Natl Acad Sci USA, 통권 : 99, pp.11736~11741 (2002)
7. Chung CH, "Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose", N Engl J Med, 358, pp.1109~1117 (2008)
8. Cox KM, "Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor", Nat Biotechnol, 24, pp.1591~1597 (2006)
9. Elliott S, "Control of rHuEPO biological activity: the role of carbohydrate", Exp Hematol, 32, pp.1146~1155 (2004)
10. Leist M, "Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo", Proc Natl Acad Sci USA, 통권 : 100, pp.6741~6746 (2003)
11. Ernst JF, "Site-specific O-glycosylation of human granulocyte", macrophage colonystimulating factor secreted by yeast and animal cells, FEBS, pp.1992, 203[DOI]
12. "FDA (US Food and Drug Administration) website"[URL]
13. Ferra C, "Modulation of therapeutic antibody effector functions by glycosylation engineering", Biotechnol Bioeng, 93, pp.851~861 (2006)
14. Flesher AR, "Fluorophorelabeled carbohydrate analysis of immunoglobulin fusion proteins", Biotechnol Bioeng, 46, pp.399~407 (1995)
15. Fujiyama K, "Change in glycosylation pattern with extension of endoplasmic reticulum retention signal sequence of mouse antibody produced by suspension-cultured tobacco BY2 cells", J Biosci Bioeng, 107, pp.165~172 (2009)
16. Gomord V, "Plant-specific glycosylation patterns in the context of therapeutic protein production", Plant Biotechnol J, 8, pp.564~857 (2010)
17. Grewal PK, "The Ashwell receptor mitigates the lethal coagulopathy of sepsis", Nat Med, 14, pp.648~655 (2008)
18. Helenius A, "Roles of N-linked glycans in the endoplasmic reticulum", Ann Rev Biochem, 73, pp.1019~1049 (2004)
19. Jin C, "A plantderived human monoclonal antibody induces an anticarbohydrate immune response in rabbits", Glycobiology, 18, pp.235~241 (2008)
20. Jones AJ, "Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys", Glycobiology, 17, pp.529~540 (2007)
21. Julenius K, "Prediction, conservation analysis and structural characterization of mammalian mucin-type O-glycosylation sites", Glycobiology, 15, pp.153~164 (2005)
22. Kaneko Y, "Antiinflammatory activity of immunoglobulin G resulting from Fc sialylation", Science, 313, pp.670~673 (2006)
23. Kelleher DJ, "Dolichol-linked oligosaccharide selection by the oligosaccharyltransferase in protist and fungal organisms", J Cell Biol, 177, pp.29~37 (2007)
24. Kelleher DJ, "The Saccharomyces cerevisiae oligosaccharyltransferase is a protein complex composed of Wbp1p, Swp1p, and four additional polypeptides", J Biol Chem, 269, pp.12908~12917 (1994)
25. Ko K, "Glyco-engineering of biotherapeutic proteins in plants", Mol Cells, 25, pp.494~503 (2008)
26. Ko K, "Function and glycosylation of plantderived antiviral monoclonal antibody", Proc Natl Acad Sci USA, 통권 : 100, pp.8013~8018 (2003)
27. Krapp S, "Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity", J Mol Biol, 325, pp.979~989 (2003)
28. Maynard Y, "Oligosaccharide specific endocytosis by isolated rat hepatic reticuloendothelial cells", J Biol Chem, 256, pp.8063~8068 (1981)
29. Nechansky A, "Compensation of endogeneous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of the therapeutic antibodies", Mol Immunol, 44, pp.1815~1817 (2007)
30. Nimmerjahn F, "Fc receptors as regulators of immune responses", Nature Rev Immunol, 8, pp.34~47 (2008)
31. Pattison RJ, "N-glycan production in the endoplasmic reticulum of plants", Trends Plant Sci, 14, pp.92~99 (2009)
32. Peipp M, "Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells", Blood, 112, pp.2390~2399 (2008)
33. Potgieter TI, "Production of monoclonal antibodies by glycoengineered Pichia pastoris", J Biotechnol, 139, pp.318~325 (2009)
34. Rademacher TW, "Glycosylation as a factor affecting product consistency", Biologicals, 21, pp.103~104 (1993)
35. Ruddock LW, "N-glycan processing in ER quality control", J Cell Sci, 119, pp.4373~4380 (2006)
36. Saint-Jore-Dupas C, "From planta to pharma with glycosylation in the toolbox", Trends Biotechnol, 25, pp.317~323 (2007)
37. Shinkawa T, "The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity", J Biol Chem, 278, pp.3466~3473 (2003)
38. Strasser R, "Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure", Plant Biotechnol J, 6, pp.392~402 (2008)
39. Tangvoranuntakul P, "Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid", Proc Natl Acad Sci USA, 통권 : 100, pp.12045~12050 (2003)
40. Umaña P, "Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity", Nat Biotechnol, 17, pp.176~180 (1999)

관련 논문AI추천